Article Information
History
- December 7, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- John Paul Shen1,*,
- Abdelrahman M. Yousef1,*,
- Fadl A. Zeineddine2,
- Mohammad A. Zeineddine1,
- Rebecca S. Tidwell3,
- Karen A. Beaty4,
- Lisa C. Scofield1,
- Safia Rafeeq4,
- Nick Hornstein1,
- Elizabeth Lano5,
- Cathy Eng7,
- Aurelio Matamoros5,
- Wai Chin Foo6,
- Abhineet Uppal4,
- Christopher Scally4,
- Paul Mansfield4,
- Melissa Taggart6,
- Kanwal P. Raghav1,*,†,
- Michael J. Overman1,*,† and
- Keith Fournier4,*,†
- 1Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 2Department of Internal Medicine, Houston Methodist Hospital, Houston, TX, USA
- 3Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 4Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 5Department of Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 6Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 7Department of Medical Oncology, Vanderbilt University, Nashville, TN, USA
- ↵†Corresponding Authors:
Kanwal P. Raghav, MD Anderson Cancer Center, 1515 Holcombe BLVD., Houston, TX 77030, Phone; 713-404-7816 email: kpraghav{at}mdanderson.org, Michael J. Overman,, MD Anderson Cancer Center, 1515 Holcombe BLVD., Houston, TX 77030, Phone; 713-792-2828 email: moverman{at}mdanderson.org, Keith Fournier, MD Anderson Cancer Center, 1515 Holcombe BLVD., Houston, TX 77030, Phone; 713-792-8826 email: kffourni{at}mdanderson.org
↵* denotes equal contribution from these authors
Posted December 07, 2022.
A Prospective Randomized Crossover Trial of Systemic Chemotherapy in Patients with Low-Grade Mucinous Appendiceal Adenocarcinoma
